| 05:39 PM |
Corporate Action-Amalgamation/ Merger / Demerger
|
| 05:35 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 05:32 PM |
Announcement under Regulation 30 (LODR)-Change in Directorate
|
| 07:26 PM |
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
|
| 10:52 PM |
Update On US Food And Drug Administration (USFDA) Inspection On Pharmathen International S.A.
|
| 08:07 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 07:30 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 05:20 PM |
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 04:10 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 08:53 PM |
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
|
| 05:52 PM |
Update On US Food And Drug Administration (USFDA) Inspection On Pharmathen International S.A.
|
| 05:57 PM |
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
|
| 07:24 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 08:43 AM |
USFDA Inspection At Invagen Manufacturing Facility In Hauppauge, Long Island, New York, USA
|
| 10:25 PM |
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 06:46 PM |
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 05:34 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 10:07 AM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 06:24 PM |
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
|
| 07:41 PM |
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
|
| 01:00 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 07:20 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 02:16 PM |
Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations,
2015
|
| 02:10 PM |
Announcement under Regulation 30 (LODR)-Change in Directorate
|
| 02:08 PM |
Board Meeting Outcome for Board Meeting Outcome For Meeting Held On 23Rd January, 2026
|
| 01:42 PM |
Announcement under Regulation 30 (LODR)-Investor Presentation
|
| 01:40 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 01:27 PM |
Financial Results For Quarter And Nine Months Ended 31St December, 2025
|
| 05:49 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 11:11 PM |
Update On Lanreotide Supply Pursuant To US Food And Drug Administration (USFDA) Inspectional Observations In Form 483 On Pharmathen International S.A.
|
| 04:40 PM |
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
|
| 06:33 PM |
Reply On Clarification Sought By Exchange
|
| 06:13 PM |
Intimation Under Regulation 30(11) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Clarification On USFDA Inspectional Observations In Form 483 On Pharmathen International S.A.
|
| 04:11 PM |
Clarification sought from Cipla Ltd
|
| 03:12 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 08:25 PM |
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Friday, 23Rd January, 2026 Inter-Alia To Consider And Approve The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December, 2025.
|
| 07:10 PM |
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 11:31 AM |
Cipla Limited Has Entered Into Exclusive Supply And Marketing Agreement For Pfizer'S Brands
|
| 05:59 PM |
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
|
| 10:24 PM |
Announcement under Regulation 30 (LODR)-Updates on Acquisition
|
| 12:50 PM |
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
|
| 05:49 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:44 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 03:31 PM |
Product Launch - Lilly And Cipla Sign Marketing And Distribution Agreement For Second Brand Of Tirzepatide In India
|
| 03:51 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 01:32 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 04:41 PM |
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday, 30Th October, 2025.
|
| 06:50 PM |
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
|
| 04:40 PM |
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 07:15 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 08:18 PM |
Announcement under Regulation 30 (LODR)-Updates on Acquisition
|
| 07:42 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:31 PM |
Intimation Of Cancellation Of Schedule Of Analyst / Institutional Investor Meetings
|
| 06:33 PM |
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 09:10 AM |
Update On USFDA Inspection At Company''s Manufacturing Facility In Bommasandra, Bengaluru, India
|
| 10:53 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 10:19 PM |
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
|
| 06:02 PM |
Clarification On The News Item Dated 1St August 2025 Titled 'Pharma Stocks Slump As Trump Shoots Letters To 17 Global Drug Majors Seeking Lower Prices' Appearing In 'Www.Moneycontrol.Com'
|
| 01:29 PM |
Clarification sought from Cipla Ltd
|
| 06:26 PM |
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 06:38 PM |
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
|
| 12:08 AM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 05:19 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 01:34 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 01:29 PM |
Announcement under Regulation 30 (LODR)-Investor Presentation
|
| 01:26 PM |
Grant Of Esops/Esars
|
| 01:21 PM |
Board Meeting Outcome for Financial Results For Quarter Ended 30Th June 2025
|
| 01:19 PM |
Financial Results For Quarter Ended 30Th June 2025
|
| 07:13 PM |
Transcript Of The 89Th Annual General Meeting
|
| 07:28 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 01:19 PM |
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
|
| 10:37 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 10:34 PM |
Shareholder Meeting / Postal Ballot-Outcome of AGM
|
| 10:31 PM |
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
|
| 07:39 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 05:18 PM |
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 05:31 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 07:51 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:45 PM |
Board Meeting Intimation for Quarter Ended 30Th June, 2025 Under SEBI Listing Regulations
|
| 06:09 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 10:08 AM |
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
|
| 04:50 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 09:19 PM |
Business Responsibility and Sustainability Reporting (BRSR)
|
| 09:14 PM |
Notice Of 89Th Annual General Meeting And Integrated Annual Report For FY 2024-25
|
| 09:10 PM |
Reg. 34 (1) Annual Report.
|
| 08:26 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 05:38 PM |
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
|
| 08:46 PM |
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 07:15 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 05:31 PM |
USFDA Inspection At Company'S Manufacturing Facility In Bommasandra, Bengaluru, India
|
| 07:43 PM |
Compliances-Reg.24(A)-Annual Secretarial Compliance
|
| 06:47 PM |
Announcement under Regulation 30 (LODR)-Updates on Acquisition
|
| 06:42 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 09:17 PM |
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
|
| 08:18 PM |
Clarification - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Submitted On 13Th May, 2025
|
| 11:40 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 05:40 PM |
Update On USFDA Inspection At Facility Of Sitec Labs Limited In Mahape, Navi Mumbai, India
|
| 04:49 PM |
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
|
| 12:36 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:56 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback